Y-K. Kang - Asan Medical Center, University of Ulsan

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 120 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Z.A. Wainberg,P.C. Enzinger, S. Qin,K. Yamaguchi, J. Wang, X. Zhou,A. Gnanasakthy, K. Taylor,A. Yusuf,I. Majer, A. Jamotte,Y.-K. Kang

ESMO Gastrointestinal Oncology (2024): 100095

引用0浏览0引用

Nivolumab in Sorafenib-Naive and Sorafenib-Experienced Patients with Advanced Hepatocellular Carcinoma: 5-Year Follow-Up from CheckMate 040

A. B. El-Khoueiry,J. Trojan, T. Meyer,T. Yau,I. Melero,M. Kudo,C. Hsu,T. -y. Kim,S. -p. Choo,Y. -k. Kang,W. Yeo,A. Chopra,S. Soleymani,J. Yao,J. Neely,M. Tschaika,T. H. Welling,B. Sangro

ANNALS OF ONCOLOGYno. 4 (2024): 381-391

引用0浏览0WOS引用

126O Nivolumab (NIVO) Plus Ipilimumab (IPI) Vs Lenvatinib (LEN) or Sorafenib (SOR) As First-Line (1L) Treatment for Unresectable Hepatocellular Carcinoma (uhcc): CheckMate 9DW Asian Subgroup Analysis

T. Yau,P.R. Galle, T. Decaens,B. Sangro, S. Qin,J-W. Park, M. Ikeda, D.W.M. Tai,C-F. Chiu,H.J. Chon,Y-K. Kang,A. Hiraoka, Y-H. Huang, T-Y. Lee,K. Numata, T. Yamashita, T. Ogata, J. Hreiki, Y. Lu, M. Kudo

Annals of Oncology (2024): S1450-S1451

引用0浏览0引用

Phase (ph) Ib results of bemarituzumab (BEMA) added to capecitabine/oxaliplatin (CAPOX) or S-1/oxaliplatin (SOX) with or without nivolumab (NIVO) for previously untreated advanced gastric/gastroesophageal junction cancer (G/ GEJC): FORTITUDE-103 study

K-W. Lee,Y-K. Kang,M-H. Chen, H. Hirano,Y. Sunakawa, S. T. Kim,C-C. Lin,W. P. Yong, T. Kawakami, T. Oshima, Z. Li, M. Hopkins, A. Levin, H. Wang, L. Goldstein,D. Zhou,S. Y. Rha

ANNALS OF ONCOLOGY（2023）

引用0浏览0引用

1523P Phase II Dose Optimization Results from MOUNTAINEER-02: A Study of Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel for HER2+ Gastroesophageal Cancer (GEC)

M. Tehfe, J. Lee,S. Y. Rha,Y. Nakamura,J. Tabernero,K. Shitara,D-Y. Oh,J. Eads, J. Marshall,Z. A. Wainberg,K-W. Lee,Y-K. Kang,C-Y. Liao,S. Y. Oh,K-H. Yeh, D. Richards, M. M. Ubowski, K. Zhao,S. Bhaumik,J. H. Strickler

Annals of Oncology (2023): S857-S858

引用0浏览0引用

Prevalence of claudin-18 isoform 2 (CLDN18.2) positivity in locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mg/GEJ) adenocarcinoma in patients (pts) in the Asia region: Phase III SPOTLIGHT and GLOW studies

Y-J. Bang,L. Shen,Y-K. Kang, Y. Chao,H. H. F. Soo,P. Sunpaweravong, D. Moran, A. Guerrero, R. Li, J. Pavese,M. Matsangou, P. Bhattacharya,K. Shitara,R-H. Xu

ANNALS OF ONCOLOGY (2023): S1527-S1528

引用0浏览0引用

LBA82 Updated Efficacy and Safety Results from Phase III SPOTLIGHT Study Evaluating Zolbetuximab + Mfolfox6 As First-Line (1L) Treatment for Patients with Claudin-18 Isoform 2-Positive (CLDN18.2+), HER2−, Locally Advanced (LA) Unresectable or Metastatic Gastric or Gastroesophageal Junction (mg/gej) Adenocarcinoma

J. A. Ajani,F. Lordick,Y-J. Bang,P. C. Enzinger,D. H. Ilson,M. A. Shah,E. van Cutsem,R-H. Xu, G. Aprile,J. Xu,R. A. Pazo Cid,Y-K. Kang, J. Yang, D. Moran, P. Bhattacharya,M. Matsangou,A. Arozullah,J. W. Park,K. Shitara

Annals of Oncology (2023): S1322-S1322

引用0浏览0引用

1526P Phase Ib Results of Bemarituzumab (bema)+mfolfox6+nivolumab (NIVO) for Advanced Gastric/gastroesophageal Junction Cancer (G/GEJC): Fortitude-102 Part 1

Z.A. Wainberg, K. Yamaguchi,J.A. Ajani,J. Chao,M. Moehler,Y-K. Kang,E. Van Cutsem, P. Yen, Y. Motii,D. Zhou, T. Murias Dos Santos,K. Shitara

Annals of Oncology (2023): S859

引用0浏览0引用

B.T. Li,K-W. Lee,M. Pegram,M.R. Sharma, J. Lee,A.I. Spira,Y-K. Kang,K.N. Moore,D. Rasco,G.J. Hanna,B.A. Weinberg, T. Yu,M. Alonso, J. Ptacek, M. Yin, C. Tapia, L. Xu, E.A. Perez,E.E. Dumbrava

Annals of Oncology (2023): S462-S463

引用0浏览0引用

Zanidatamab (zani) plus chemotherapy (chemo) and tislelizumab (tis) as first-line (1l) therapy for patients (pts) with advanced HER2-positive (+) gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): Updated results from a phase Ib/II study

K-W. Lee,L-Y. Bai, M. Jung,J. Ying, Y-H. Im, D-Y. Oh,J. Y. Cho, S. C. Oh,Y. Chao, P. Zhou,Y. Bao,Y-K. Kang

ANNALS OF ONCOLOGY (2023): S855-S856

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn